Feng-MingPhoenixKongMD

Radiation Oncology • Cleveland, OH

Physician

Join to view full profile

Dr. Kong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kong's full profile

Already have an account?

Office
11100 Euclid Avenue
Cleveland, OH 44106
Phone+1 216-286-6740

Fax+1 216-201-6623

Summary

Yes I am an American board certified radiation oncologist and Professor with over 200 publications and NIH R01 grant. I had postdoctoral training from Duke University Medical Center, and finished my radiation oncology residency program at Washington University at St. Louis.

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 1999 - 2003
University of Vermont Medical CenterInternship, Transitional Year, 1998 - 1999
Shanghai Medical UniversityClass of 1985

Certifications & Licensure

OH State Medical License 2018 - 2026
GA State Medical License 2013 - 2019
IN State Medical License 2016 - 2019
MI State Medical License 2003 - 2016
VT State Medical License 1998 - 1999

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer Start of enrollment: 2007 May 01
Completed
Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer Start of enrollment: 2008 Aug 01
Completed
Not Applicable
Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer Start of enrollment: 2012 Feb 22
Active, not recruiting
Phase 2
Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC Start of enrollment: 2012 Dec 01
Active, not recruiting
Phase 2
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer Start of enrollment: 2017 May 01
Terminated
Join now to see all

Publications & Presentations

PubMed

9 citations
Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
Xiate Zhou, Wei Wang, Chao Zhou, Jian Zhu, Weijun Ding
Radiotherapy and Oncology. 2022-05-01
Effect of bladder volume on radiation doses to organs at risk and tumor in cervical cancer during image-guided adaptive brachytherapy and treatment outcome analysis.
Zhiyuan Xu, Li Yang, Lingyu Ma, Qin Liu, Amy Ty Chang
Molecular and Clinical Oncology. 2021-10-15
5 citations
Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer.
Hong Zhang, Weili Wang, Pi Wenhu, Nan Bi, Colleen DesRosiers
Frontiers in Oncology. 2021-07-07

Journal Articles

Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer
Feng-Ming Kong, Nirav Kapadia, The Annals of Thoracic Surgery

Lectures

The effect of thoracic radiation on overall survival and their association with systemic immune therapy in stage IV NSCLC: Findings from the National Cancer Database.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Long-term survival comparison of stereotactic radiotherapy versus surgery for elderly patients with clinical stage T1-T2 non-small cell lung cancer.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018